Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China

This protocol was developed to conduct population-wide surveillance of the bivalent HPV-16/18-AS04-adjuvanted human papillomavirus (HPV) vaccine in terms of uptake and safety outcomes including potential immune-mediated diseases (pIMDs) and pregnancy-related outcomes in China. The study will use ele...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Junting Yang, Sarah Welby, Zhike Liu, Siwei Deng, Guangxu Liu, Ruogu Meng, Yu Yang, Yixin Sun, Yunkun He, Ning Jiang, Zhenhua Wu, Keruo Liu, Dominique Rosillon, Catherine Cohet, Siyan Zhan
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2024-12-01
Edice:	Human Vaccines & Immunotherapeutics
Témata:	HPV-16/18-AS04 human papillomavirus vaccine safety potential immune-mediated diseases pregnancy outcomes
On-line přístup:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2378535
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!